Tenet Healthcare Corporation (NYSE:THC) Receives $244.16 Consensus Price Target from Analysts

Shares of Tenet Healthcare Corporation (NYSE:THC) have been assigned an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $244.1579.

A number of research firms recently issued reports on THC. Weiss Ratings restated a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th. Jefferies Financial Group increased their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Truist Financial increased their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Finally, Barclays reduced their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th.

Insider Transactions at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. Insiders sold 46,517 shares of company stock valued at $10,943,111 over the last quarter. Company insiders own 0.81% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Triumph Capital Management purchased a new stake in shares of Tenet Healthcare during the third quarter worth about $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare during the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new stake in Tenet Healthcare during the 4th quarter worth approximately $29,000. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at approximately $32,000. Finally, Westside Investment Management Inc. grew its position in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Trading Down 1.1%

Shares of THC opened at $196.39 on Friday. Tenet Healthcare has a 1-year low of $146.60 and a 1-year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The firm has a 50 day simple moving average of $199.44 and a 200-day simple moving average of $203.75. The stock has a market cap of $16.92 billion, a price-to-earnings ratio of 10.21, a price-to-earnings-growth ratio of 1.32 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the prior year, the firm earned $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts forecast that Tenet Healthcare will post 17.56 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.